| 原文 | 英語 |
|---|---|
| 文章編號 | 477 |
| 期刊 | Annals of Translational Medicine |
| 卷 | 5 |
| 發行號 | 23 |
| DOIs | |
| 出版狀態 | 已發佈 - 十二月 1 2017 |
指紋
ASJC Scopus subject areas
- Medicine(all)
引用此文
The ODYSSEY DM-DYSLIPIDEMIA trial : Confirming the benefits of alirocumab in diabetic mixed dyslipidemia. / Chan, Paul; Shao, Li; Tomlinson, Brian; Liu, Zhong Min.
於: Annals of Translational Medicine, 卷 5, 編號 23, 477, 01.12.2017.研究成果: 雜誌貢獻 › 社論
}
TY - JOUR
T1 - The ODYSSEY DM-DYSLIPIDEMIA trial
T2 - Confirming the benefits of alirocumab in diabetic mixed dyslipidemia
AU - Chan, Paul
AU - Shao, Li
AU - Tomlinson, Brian
AU - Liu, Zhong Min
PY - 2017/12/1
Y1 - 2017/12/1
UR - http://www.scopus.com/inward/record.url?scp=85037134727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85037134727&partnerID=8YFLogxK
U2 - 10.21037/atm.2017.10.26
DO - 10.21037/atm.2017.10.26
M3 - Editorial
AN - SCOPUS:85037134727
VL - 5
JO - Annals of Translational Medicine
JF - Annals of Translational Medicine
SN - 2305-5839
IS - 23
M1 - 477
ER -